Kazia Therapeutics KZIA
NASDAQ KZIA
$9.47 -0.13 (-1.30%)
At close: Oct 1, 2026 · 4:00 PM EDT

Kazia Therapeutics (KZIA) Share-based Compensation (IS) (2009 - 2013)

Updated

Kazia Therapeutics (KZIA) reported Share-based Compensation (IS) of -$372,547 for the quarter ended Dec 31, 2013.

Analysis

Kazia Therapeutics (KZIA) Share-based Compensation (IS) (2009 - 2013) Analysis & Trends

For the year ended Dec 31, 2013, Kazia Therapeutics posted Share-based Compensation (IS) of -$389,475.

  • By year, Share-based Compensation (IS) came in at -$513,610 in the year ended Dec 31, 2012, -$502,831 in the year ended Dec 31, 2011, $642,291 in the year ended Jun 30, 2010 and $840,778 in the year ended Dec 31, 2009.
  • The figure for the quarter ended Dec 31, 2013 ranks as the lowest quarterly Share-based Compensation (IS) since the quarter ended Dec 31, 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Kazia Therapeutics 70.77 Mn 70.77 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 -372,546.63
Aug 30, 2013 -370,415.50
Dec 31, 2012 -515,189.70
Jun 30, 2010 643,578.42
Dec 31, 2009 -1.20 Mn
API Access

Kazia Therapeutics Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=KZIA&period=max&api_key=YOUR_API_KEY